Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

"Creating a Favorable Micro-Environment for Fat Grafting in a Novel Model of Radiation Induced Mammary Fat Pad Fibrosis."

Truong JL, Liu M, Tolg C, Barr M, Dai C, Raissi TC, Wong E, DeLyzer T, Yazdani A, Turley EA.

Plast Reconstr Surg. 2019 Sep 30. doi: 10.1097/PRS.0000000000006344. [Epub ahead of print]

PMID:
31577661
2.

Dissecting the Dual Nature of Hyaluronan in the Tumor Microenvironment.

Liu M, Tolg C, Turley E.

Front Immunol. 2019 May 10;10:947. doi: 10.3389/fimmu.2019.00947. eCollection 2019. Review.

3.

Predictors of the Performance of Early Antireflux Surgery in Esophageal Atresia.

François B, Michaud L, Sfeir R, Bonnard A, Rousseau V, Blanc S, Gelas T, Boubnova J, Jacquier C, Irtan S, Breton A, Fouquet V, Guinot A, Lamireau T, Habounimana E, Schneider A, Elbaz F, Ranke A, Poli-Merol ML, Kalfa N, Dupont-Lucas C, Petit T, Michel JL, Buisson P, Lirussi-Borgnon J, Sapin E, Lardy H, Levard G, Parmentier B, Cremillieux C, Lopez M, Podevin G, Schmitt F, Borderon C, Jaby O, Pelatan C, De Vries P, Pouzac-Arnould M, Grosos C, Breaud J, Laplace C, Tolg C, Sika A, Auber F, Labreuche J, Duhamel A, Gottrand F.

J Pediatr. 2019 Aug;211:120-125.e1. doi: 10.1016/j.jpeds.2019.03.045. Epub 2019 May 6.

PMID:
31072651
4.

Spatial statistical tools for genome-wide mutation cluster detection under a microarray probe sampling system.

Luo B, Edge AK, Tolg C, Turley EA, Dean CB, Hill KA, Kulperger RJ.

PLoS One. 2018 Sep 25;13(9):e0204156. doi: 10.1371/journal.pone.0204156. eCollection 2018.

5.

A truncated RHAMM protein for discovering novel therapeutic peptides.

Hauser-Kawaguchi A, Tolg C, Peart T, Milne M, Turley EA, Luyt LG.

Bioorg Med Chem. 2018 Oct 1;26(18):5194-5203. doi: 10.1016/j.bmc.2018.09.018. Epub 2018 Sep 18.

PMID:
30249497
6.

Thoracic skeletal anomalies following surgical treatment of esophageal atresia. Lessons from a national cohort.

Bastard F, Bonnard A, Rousseau V, Gelas T, Michaud L, Irtan S, Piolat C, Ranke-Chrétien A, Becmeur F, Dariel A, Lamireau T, Petit T, Fouquet V, Le Mandat A, Lefebvre F, Allal H, Borgnon J, Boubnova J, Habonimana E, Panait N, Buisson P, Margaryan M, Michel JL, Gaudin J, Lardy H, Auber F, Borderon C, De Vries P, Jaby O, Fourcade L, Lecompte JF, Tolg C, Delorme B, Schmitt F, Podevin G.

J Pediatr Surg. 2018 Apr;53(4):605-609. doi: 10.1016/j.jpedsurg.2017.07.013. Epub 2017 Jul 21.

PMID:
28778692
7.

Hyaluronan modulates growth factor induced mammary gland branching in a size dependent manner.

Tolg C, Yuan H, Flynn SM, Basu K, Ma J, Tse KCK, Kowalska B, Vulkanesku D, Cowman MK, McCarthy JB, Turley EA.

Matrix Biol. 2017 Nov;63:117-132. doi: 10.1016/j.matbio.2017.02.003. Epub 2017 Feb 21.

PMID:
28232112
8.

Receptor for hyaluronan mediated motility (RHAMM/HMMR) is a novel target for promoting subcutaneous adipogenesis.

Bahrami SB, Tolg C, Peart T, Symonette C, Veiseh M, Umoh JU, Holdsworth DW, McCarthy JB, Luyt LG, Bissell MJ, Yazdani A, Turley EA.

Integr Biol (Camb). 2017 Mar 1;9(3):223-237. doi: 10.1039/c7ib00002b. Epub 2017 Feb 20.

9.

Uropathogenic E. coli (UPEC) Infection Induces Proliferation through Enhancer of Zeste Homologue 2 (EZH2).

Ting K, Aitken KJ, Penna F, Samiei AN, Sidler M, Jiang JX, Ibrahim F, Tolg C, Delgado-Olguin P, Rosenblum N, Bägli DJ.

PLoS One. 2016 Mar 10;11(3):e0149118. doi: 10.1371/journal.pone.0149118. eCollection 2016.

10.

Uncovering the dual role of RHAMM as an HA receptor and a regulator of CD44 expression in RHAMM-expressing mesenchymal progenitor cells.

Veiseh M, Leith SJ, Tolg C, Elhayek SS, Bahrami SB, Collis L, Hamilton S, McCarthy JB, Bissell MJ, Turley E.

Front Cell Dev Biol. 2015 Oct 15;3:63. doi: 10.3389/fcell.2015.00063. eCollection 2015.

11.

Identification, design and synthesis of tubulin-derived peptides as novel hyaluronan mimetic ligands for the receptor for hyaluronan-mediated motility (RHAMM/HMMR).

Esguerra KV, Tolg C, Akentieva N, Price M, Cho CF, Lewis JD, McCarthy JB, Turley EA, Luyt LG.

Integr Biol (Camb). 2015 Dec;7(12):1547-60. doi: 10.1039/c5ib00222b. Epub 2015 Oct 12.

12.

Hyaluronan-phosphatidylethanolamine polymers form pericellular coats on keratinocytes and promote basal keratinocyte proliferation.

Symonette CJ, Kaur Mann A, Tan XC, Tolg C, Ma J, Perera F, Yazdani A, Turley EA.

Biomed Res Int. 2014;2014:727459. doi: 10.1155/2014/727459. Epub 2014 Sep 9.

13.

Hyaluronan and RHAMM in wound repair and the "cancerization" of stromal tissues.

Tolg C, McCarthy JB, Yazdani A, Turley EA.

Biomed Res Int. 2014;2014:103923. doi: 10.1155/2014/103923. Epub 2014 Aug 4. Review.

14.

Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.

Veiseh M, Kwon DH, Borowsky AD, Tolg C, Leong HS, Lewis JD, Turley EA, Bissell MJ.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):E1731-9. doi: 10.1073/pnas.1402383111. Epub 2014 Apr 14.

15.

Specific sizes of hyaluronan oligosaccharides stimulate fibroblast migration and excisional wound repair.

Tolg C, Telmer P, Turley E.

PLoS One. 2014 Feb 13;9(2):e88479. doi: 10.1371/journal.pone.0088479. eCollection 2014.

16.

Phenotypic switching induced by damaged matrix is associated with DNA methyltransferase 3A (DNMT3A) activity and nuclear localization in smooth muscle cells (SMC).

Jiang JX, Aitken KJ, Sotiropoulos C, Kirwan T, Panchal T, Zhang N, Pu S, Wodak S, Tolg C, Bägli DJ.

PLoS One. 2013 Aug 7;8(8):e69089. doi: 10.1371/journal.pone.0069089. eCollection 2013. Erratum in: PLoS One. 2013;8(10). doi:10.1371/annotation/c825c71c-bb8a-456f-9ed4-83969a76429c. Sotiropolous, Chris [corrected to Sotiropoulos, Chris].

17.

Pathologic bladder microenvironment attenuates smooth muscle differentiation of skin derived precursor cells: implications for tissue regeneration.

Tolg C, Ahsan A, Dworski S, Kirwan T, Yu J, Aitken K, Bägli DJ.

PLoS One. 2013;8(4):e59413. doi: 10.1371/journal.pone.0059413. Epub 2013 Apr 1.

18.

Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling.

Zeilstra J, Joosten SP, van Andel H, Tolg C, Berns A, Snoek M, van de Wetering M, Spaargaren M, Clevers H, Pals ST.

Oncogene. 2014 Jan 30;33(5):665-70. doi: 10.1038/onc.2012.611. Epub 2013 Jan 14.

PMID:
23318432
19.

A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.

Tolg C, Hamilton SR, Zalinska E, McCulloch L, Amin R, Akentieva N, Winnik F, Savani R, Bagli DJ, Luyt LG, Cowman MK, McCarthy JB, Turley EA.

Am J Pathol. 2012 Oct;181(4):1250-70. doi: 10.1016/j.ajpath.2012.06.036. Epub 2012 Aug 11.

20.

Uropathogenic Escherichia coli infection: potential importance of epigenetics.

Tolg C, Bägli DJ.

Epigenomics. 2012 Apr;4(2):229-35. doi: 10.2217/epi.12.5.

PMID:
22449193
21.

How does a protein with dual mitotic spindle and extracellular matrix receptor functions affect tumor susceptibility and progression?

Telmer PG, Tolg C, McCarthy JB, Turley EA.

Commun Integr Biol. 2011 Mar;4(2):182-5. doi: 10.4161/cib.4.2.14270.

22.

Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells.

Tolg C, Sabha N, Cortese R, Panchal T, Ahsan A, Soliman A, Aitken KJ, Petronis A, Bägli DJ.

Lab Invest. 2011 Jun;91(6):825-36. doi: 10.1038/labinvest.2010.197. Epub 2011 Jan 17.

23.

RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.

Tolg C, Hamilton SR, Morningstar L, Zhang J, Zhang S, Esguerra KV, Telmer PG, Luyt LG, Harrison R, McCarthy JB, Turley EA.

J Biol Chem. 2010 Aug 20;285(34):26461-74. doi: 10.1074/jbc.M110.121491. Epub 2010 Jun 17.

24.

Mammalian target of rapamycin (mTOR) induces proliferation and de-differentiation responses to three coordinate pathophysiologic stimuli (mechanical strain, hypoxia, and extracellular matrix remodeling) in rat bladder smooth muscle.

Aitken KJ, Tolg C, Panchal T, Leslie B, Yu J, Elkelini M, Sabha N, Tse DJ, Lorenzo AJ, Hassouna M, Bägli DJ.

Am J Pathol. 2010 Jan;176(1):304-19. doi: 10.2353/ajpath.2010.080834. Epub 2009 Dec 17.

25.

The hyaluronan receptors CD44 and Rhamm (CD168) form complexes with ERK1,2 that sustain high basal motility in breast cancer cells.

Hamilton SR, Fard SF, Paiwand FF, Tolg C, Veiseh M, Wang C, McCarthy JB, Bissell MJ, Koropatnick J, Turley EA.

J Biol Chem. 2007 Jun 1;282(22):16667-80. Epub 2007 Mar 28.

26.

Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.

Tolg C, Hamilton SR, Nakrieko KA, Kooshesh F, Walton P, McCarthy JB, Bissell MJ, Turley EA.

J Cell Biol. 2006 Dec 18;175(6):1017-28. Epub 2006 Dec 11.

27.

Open vs thorascopic surgical management of bronchogenic cysts.

Tölg C, Abelin K, Laudenbach V, de Heaulme O, Dorgeret S, Lipsyc ES, Aigrain Y, de Lagausie P.

Surg Endosc. 2005 Jan;19(1):77-80.

PMID:
15549633
28.
29.
30.

Splicing choice from ten variant exons establishes CD44 variability.

Tölg C, Hofmann M, Herrlich P, Ponta H.

Nucleic Acids Res. 1993 Mar 11;21(5):1225-9.

31.

CD44 splice variants confer metastatic behavior in rats: homologous sequences are expressed in human tumor cell lines.

Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U.

Cancer Res. 1991 Oct 1;51(19):5292-7.

Supplemental Content

Support Center